Quick Answer
GoodRx Holdings, Inc. reported Total Revenue of $796.85 million for fiscal year 2025.
GoodRx Holdings, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $796.85M +0.6% |
$792.32M +5.6% |
$750.26M -2.1% |
$766.55M +2.8% |
$745.42M +35.4% |
$550.70M +41.9% |
| Revenue (ASC 606) | $796.85M +0.6% |
$792.32M +5.6% |
$750.26M -2.1% |
$766.55M +2.8% |
$745.42M +35.4% |
$550.70M +41.9% |
| Net Income | $30.44M +85.7% |
$16.39M +284.8% |
-$8.87M +73.0% |
-$32.83M -30.0% |
-$25.25M +91.4% |
-$293.62M -544.6% |
| Diluted EPS | $0.09 +125.0% |
$0.04 +300.0% |
-$0.02 +75.0% |
-$0.08 -33.3% |
-$0.06 +94.4% |
-$1.07 -694.4% |
| Total Assets | $1.40B +1.2% |
$1.39B -12.6% |
$1.59B -1.0% |
$1.60B -0.2% |
$1.61B +9.4% |
$1.47B +280.1% |
| Cash and Equivalents | $261.82M -41.6% |
$448.35M -33.3% |
$672.30M -11.2% |
$757.16M -19.5% |
$941.11M -2.8% |
$968.69M +3618.6% |
| Long-Term Debt | $483.26M -0.7% |
$486.71M -24.9% |
$647.70M -0.6% |
$651.80M -0.6% |
$655.86M -0.6% |
$659.89M -0.6% |
| Stockholders Equity | $616.26M -15.0% |
$724.66M -4.9% |
$761.96M -6.5% |
$814.83M -2.0% |
$831.68M +16.9% |
$711.36M +165.4% |
| R&D Expense | $121.03M -2.2% |
$123.75M -8.9% |
$135.84M -5.1% |
$143.14M +13.7% |
$125.86M +103.6% |
$61.82M +111.0% |
| Operating Income | $87.49M +32.9% |
$65.85M +343.8% |
-$27.01M -1653.9% |
$1.74M -87.0% |
$13.41M +104.9% |
-$275.72M -297.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $196.03M | +0.4% | -3.5% |
| Revenue (ASC 606) | September 30, 2025 | $196.03M | +0.4% | -3.5% |
| Net Income | September 30, 2025 | $1.12M | -71.8% | -91.3% |
| Diluted EPS | September 30, 2025 | $0.00 | -100.0% | -100.0% |
| Total Assets | September 30, 2025 | $1.33B | -2.2% | +0.5% |
| Cash and Equivalents | September 30, 2025 | $273.53M | -35.5% | -2.8% |
| Long-Term Debt | September 30, 2025 | $484.11M | -0.7% | -0.2% |
| Stockholders Equity | September 30, 2025 | $600.71M | -13.7% | -6.6% |
| R&D Expense | September 30, 2025 | $31.01M | +2.9% | +3.6% |
| Operating Income | September 30, 2025 | $14.62M | -28.4% | -45.5% |
- GoodRx Holdings, Inc. reported Total Revenue of $796.85 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +0.6% in Total Revenue compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Revenue (ASC 606) of $796.85 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +0.6% in Revenue (ASC 606) compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Net Income of $30.44 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +85.7% in Net Income compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Diluted EPS of $0.09 per share for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +125.0% in Diluted EPS compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Total Assets of $1.40 billion for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +1.2% in Total Assets compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Cash and Equivalents of $261.82 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed a decrease of -41.6% in Cash and Equivalents compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Long-Term Debt of $483.26 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed a decrease of -0.7% in Long-Term Debt compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Stockholders Equity of $616.26 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed a decrease of -15.0% in Stockholders Equity compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported R&D Expense of $121.03 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed a decrease of -2.2% in R&D Expense compared to the prior fiscal year.
- GoodRx Holdings, Inc. reported Operating Income of $87.49 million for fiscal year 2025.
- GoodRx Holdings, Inc. showed an increase of +32.9% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: